Sprint Bioscience is an innovative company that develops small-molecule drug candidates with the potential to become first-in-class, that can fight cancer either individually or in combination with other drugs. Our current attention is immuno-oncology and tumor metabolism. We have established a broad portfolio of preclinical drug projects, three of which have been licensed to international pharmaceutical companies.
TATAA Biocenter was founded in 2001 by pioneers in molecular analyses of nucleic acids. TATAA Biocenter offers a full range of qPCR, dPCR and Next-Generation Sequencing research services, several based on proprietary technology such as Two-Tailed PCR and direct blood genotyping. TATAA develops and performs a broad spectrum of hands-on courses world-wide and offers carefully chosen high-quality products for qPCR and NGS applications.
Vironova is a Swedish biotechnology company providing comprehensive hardware, software, and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy based image analysis in biopharmaceutical development and biomedical research. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.